Twist Bioscience (TWST) Reports Q1 Loss, Tops Revenue Estimates
Portfolio Pulse from
Twist Bioscience (TWST) reported a Q1 loss of $0.53 per share, which was better than the Zacks Consensus Estimate of a $0.62 loss. This is an improvement from the $0.75 loss per share reported a year ago.
February 03, 2025 | 2:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Twist Bioscience reported a Q1 loss of $0.53 per share, beating the Zacks Consensus Estimate of a $0.62 loss. This marks an improvement from the previous year's $0.75 loss per share.
The better-than-expected earnings report, with a smaller loss than anticipated, is likely to have a positive impact on TWST's stock price in the short term. The improvement from the previous year's loss also suggests positive momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100